Bisolvon bromhexinhydrochloride

Bisolvon is a brand of bromhexine hydrochloride, a mucolytic agent used to alleviate chest congestion by breaking down mucus. Developed in the late 1950s by Boehringer Ingelheim, it was patented in 1961 and introduced in 1963 under the Bisolvon trademark. The brand has since been marketed globally, with manufacturing facilities in various countries to meet international demand. Over the years, Bisolvon has been produced in multiple countries, including Germany, Australia, and Indonesia, among others. The brand is currently owned by Boehringer Ingelheim, a global pharmaceutical company headquartered in Germany. In Sweden, Bisolvon is distributed by local subsidiaries to ensure compliance with national regulations and to effectively serve the Swedish market.